Discussion around ROSE centers on its major Equifax partnership and the Eden 24.0 privacy upgrade. This optimism is tempered by concerns over a large upcoming token unlock and unconfirmed delisting rumors, leading to a cautious community outlook.
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content.See T&Cs.